HMIS indicators to STOP TB Program
• TB patients on DOTS (number of new
smear-positive pulmonary TB cases
• TB case detection (number of new
smear-positive pulmonary TB cases
smearnegative pulmonary TB cases
detected, number of new extra-
pulmonary TB cases detected)
• HIV-TB co-infection (proportion of newly
diagnosed TB cases tested for HIV)
• HIV+ new TB patients enrolled in DOTS
• TB treatment outcome (treatment
completed PTB+, cured PTB+, defaulted
(RIPE treatment – rifampicin, isoniazid,
pyrazinamide, ethambutol)